Cover Image
市場調查報告書

誘導性多功能幹細胞(iPS細胞):全球市場

Induced Pluripotent Stem Cells: Global Markets

出版商 BCC Research 商品編碼 306082
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
誘導性多功能幹細胞(iPS細胞):全球市場 Induced Pluripotent Stem Cells: Global Markets
出版日期: 2014年06月20日 內容資訊: 英文 115 Pages
簡介

全球誘導性多功能幹細胞(iPS細胞)市場2012年為8億5,300萬美元,2013年微12億美金,平均成長率微40%。預計該市場2018年達到29億美元,2013∼2018年的年複合成長率為19.7%。

本報告提供全球誘導性多功能幹細胞(iPS細胞)的概要,與近幾年的市場資料、未來市場預測、研究趨勢、市場影響成長要素等,以及參與企業簡介彙整。

第1章 簡介

第2章 市場摘要

第3章 概要

  • 簡介
  • 歷史和現狀
  • 誘導性多功能幹細胞(iPS細胞)研究的發展
  • iPS細胞的優點與缺點
  • 技術概要
    • iPS細胞的世代
  • iPS細胞的差異化

第4章 iPS細胞的應用

  • 學術研究
  • 藥物毒性篩檢
  • 疾病建模
  • 組織工程
  • 細胞療法

第5章 iPS細胞市場區隔與預測

  • 市場概要
  • 應用為基礎市場概要
  • 美國市場
  • iPS細胞開採組織細胞市場
  • iPS細胞與衍生細胞市場
  • iPS細胞產品的主要的供應商和廠商
  • 各應用iPS細胞市場
  • 各產品功能iPS細胞市場
  • 各應用iPS細胞衍生細胞市場
    • 從iPS細胞市場衍生的人體心肌細胞
    • 從iPS細胞市場衍生的人體肝細胞
    • 從iPS細胞市場衍生的人體內皮層細胞
    • 從iPS細胞市場衍生的人體神經系統細胞
  • 類別iPS細胞及其衍生細胞市場

第6章 iPS細胞研究應用市場

  • 產品的種類
  • 主要加入企業
  • 市場佔有率與預測

第7章 藥物研發及開發市場

  • 產品的種類
  • 主要加入企業
  • 市場佔有率與預測

第8章 iPS細胞契約服務市場

  • 產品的種類
  • 主要加入企業
  • 市場佔有率與預測

第9章 iPS細胞臨床應用市場

  • 產品的種類
  • 法律規章
  • 市場預測

第10章 研究市場趨勢分析

  • 津貼分析
  • 專利分析
  • 科學雜誌出版分析
  • 推動力

第11章 臨床市場趨勢分析

  • 臨床實驗
  • 推動力
  • 阻礙要素

第12章 企業簡介

  • AXIOGENESIS AG
  • CELLECTICS
  • CELLULAR DYNAMICS INC.
  • FATE THERAPEUTICS
  • IPERIAN
  • LONZA
  • REPROCELL INC.
  • STEMGENT INC.
  • SYSTEM BIOSCIENCES INC.
  • VIACYTE
  • WAISMAN BIOMANUFACTURING

第13章 結論

圖表

目錄
Product Code: BIO135A

REPORT HIGHLIGHTS

The global market for induced pluripotent stem cells (iPSCs) was estimated to total $853 million in 2012, and close to $1.2 billion in 2013, averaging 40% growth. The market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018.

This report provides:

  • An overview of the global market for induced pluripotent stem cells.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Information on induced pluripotent stem cell research products, defined as all research tools including but not limited to: induced pluripotent stem cells and various differentiated cells derived from induced pluripotent stem cells, various related assays and kits, culture media and medium components such as serum, growth factors and inhibitors, antibodies, enzymes, and many others that can be applied for the specific purpose of executing induced pluripotent stem cell research.
  • Discussion of important manufacturers, technologies, and factors influencing market demand such as the driving forces and limiting factors of induced pluripotent stem cell market growth.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2018.

This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for the entire iPSCs market are analyzed.

REASONS FOR DOING THIS STUDY

Detailed market and industry analysis for the iPSCs market is needed. As a breakthrough technology recognized by 2012 Nobel Physiology and Medicine Prize, iPSCs technology may bring a revolutionary change to modern medicine. Great opportunities always exist with high risks, but the detailed analysis and forecasts of the iPSC market can provide useful information for all management levels to help make strategic decisions in related areas.

iPSC-related products are forming an emerging market despite the fact that iPSC clinical applications are still under development. The potential scope of the iPSC market is becoming clear, and it is appropriate to review the emerging market, see the current size and share of each segment, evaluate the market trends and look to its future.

SCOPE OF REPORT

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells, and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by analyzing the funding, patent publications and sales trends of major players in the field.

ANALYST CREDENTIALS

Mike Fan has more than 20 years experience in biotech research and development (R&D) and life science marketing from academics and industry. Dr. Fan has a broad range of experience in chemical, biochemical and biomedical areas, including biochemical engineering (e.g., microbial fermentation, biocatalysis, metabolic engineering), chemical synthesis, biomedical engineering (e.g., biomedical instrument development, microarray technologies), molecular genetics, genetic analysis, drug discovery, cancer biology, cancer immunology, targeted therapy and stem cell research. He holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - MARKET SUMMARY

  • KEY DRIVERS FOR MARKET GROWTH
  • SUMMARY TABLE: GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, 2012-2018 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • INTRODUCTION
  • HISTORY AND CURRENT STATE
  • EVOLUTION OF INDUCED PLURIPOTENT STEM CELL RESEARCH
  • INDUCED PLURIPOTENT STEM CELL ADVANTAGES AND DISADVANTAGES
    • ADVANTAGES
    • DISADVANTAGES
  • TECHNOLOGY OVERVIEW
    • INDUCED PLURIPOTENT STEM CELL GENERATION
      • Retrovirus and Lentivirus
      • Adenovirus
      • Sendai Virus
      • Episomal Plasmids
      • PiggyBac
      • Minicircle Vectors
      • Synthetic mRNA
      • Protein
      • Small-Molecular Chemicals
    • INDUCED PLURIPOTENT STEM CELL DIFFERENTIATION
      • Cardiomyocytes
      • Hepatocytes
      • Neurons
      • Endothelia Cells

CHAPTER 4 - INDUCED PLURIPOTENT STEM CELL APPLICATIONS

  • ACADEMIC RESEARCH
  • PHARMACO-TOXICOLOGICAL SCREENING
  • DISEASE MODELING
  • TISSUE ENGINEERING
  • CELL THERAPY

CHAPTER 5 - INDUCED PLURIPOTENT STEM CELL MARKET SEGMENTATION AND FORECAST

  • INDUCED PLURIPOTENT STEM CELL MARKET OVERVIEW
    • FIGURE 1: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY REGION, 2018 (%)
    • TABLE 1: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY STATE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 2: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY STATE, 2018 (%)
    • TABLE 2: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, THROUGH 2018 ($ MILLIONS)
    • FIGURE 3: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, MARKET SHARES, 2018 (%)
    • TABLE 3: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, THROUGH 2018 ($ MILLIONS)
    • FIGURE 4: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELL, MARKET SHARES, 2018 (%)
  • APPLICATION-BASED MARKET OVERVIEW
    • TABLE 4: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 5: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY APPLICATION, 2018 (%)
  • U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET
    • TABLE 5: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 6: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, MARKET SHARES, 2018 (%)
  • INDUCED PLURIPOTENT STEM CELL-DERIVED TISSUE CELL MARKET
    • TABLE 6: INDUCED PLURIPOTENT STEM CELL-DERIVED TISSUE CELL MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 7: INDUCED PLURIPOTENT STEM CELL-DERIVED TISSUE CELL MARKET SHARES BY TYPE, 2018 (%)
  • INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET
    • TABLE 7: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
  • MAJOR SUPPLIERS AND MANUFACTURERS OF INDUCED PLURIPOTENT STEM CELL PRODUCTS
    • TABLE 8: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT SUPPLIERS, DECEMBER 31, 2013
    • FIGURE 8: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL SUPPLIERS BY COUNTRY, 2013
    • FIGURE 9: MAJOR U.S. COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT SUPPLIERS BY STATE, 2013
    • TABLE 9: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL CELLULAR PRODUCT MANUFACTURERS, DECEMBER 31, 2013
    • FIGURE 10: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT MANUFACTURERS BY COUNTRY, 2013
    • FIGURE 11: MAJOR U.S. COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT MANUFACTURERS BY STATE, 2013
  • INDUCED PLURIPOTENT STEM CELL-DERIVED CELL MARKETS BY APPLICATION
    • TABLE 10: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 12: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL MARKET SHARES BY APPLICATION, 2018 (%)
  • INDUCED PLURIPOTENT STEM CELL MARKET BY PRODUCT FUNCTION
    • GLOBAL MARKET
      • TABLE 11: INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY PRODUCT FUNCTION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 13: INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • REGIONAL MARKETS
      • TABLE 12: U.S. INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKETS BY PRODUCT FUNCTION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 14: U.S. INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • RESEARCH MARKET VERSUS CLINICAL MARKET
      • TABLE 13: INDUCED PLURIPOTENT STEM CELL MARKETS, THROUGH 2018 ($ MILLIONS)
      • FIGURE 15: INDUCED PLURIPOTENT STEM CELL MARKET SHARES, 2018 (%)
  • APPLICATION-BASED MARKETS FOR INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS
    • HUMAN CARDIOMYOCYTES DERIVED FROM INDUCED PLURIPOTENT STEM CELLS MARKET
      • Global Market
        • TABLE 14: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 16: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
      • Regional Markets
        • TABLE 15: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 17: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 16: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 18: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 17: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 19: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • HUMAN HEPATOCYTES DERIVED FROM INDUCED PLURIPOTENT STEM CELLS MARKET
      • Global Market
        • TABLE 18: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 20: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
      • Regional Markets
        • TABLE 19: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 21: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 20: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 22: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 21: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 23: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • HUMAN ENDOTHELIA CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS MARKET
      • Global Market
        • TABLE 22: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 24: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
      • Regional Markets
        • TABLE 23: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 25: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 24: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 26: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 25: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 27: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • HUMAN NEURAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELL MARKET
      • Global Market
        • TABLE 26: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 28: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
      • Regional Markets
        • TABLE 27: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 29: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 28: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 30: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
        • TABLE 29: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 31: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
  • INDUCED PLURIPOTENT STEM CELLS AND THEIR DERIVED CELLS MARKET BY SPECIES
    • GLOBAL MARKET
      • TABLE 30: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
      • FIGURE 32: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET SHARES BY SPECIES, 2018 (%)
    • REGIONAL MARKETS
      • TABLE 31: U.S. INDUCED PLURIPOTENT STEM CELLS AND DERIVATIVE CELLS MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
      • TABLE 32: EUROPEAN INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
      • TABLE 33: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELLS AND DERIVATIVE CELLS MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • INDUCED PLURIPOTENT STEM CELL CULTURE MARKETS
      • TABLE 34: CELL CULTURE PRODUCTS FOR INDUCED PLURIPOTENT STEM CELLS AND DERIVED CELLS MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 33: INDUCED PLURIPOTENT STEM CELL CULTURE PRODUCT MARKET SHARES BY REGION, 2018 (%)

CHAPTER 6 - INDUCED PLURIPOTENT STEM CELL RESEARCH APPLICATION MARKET

  • INDUCED PLURIPOTENT STEM CELL RESEARCH PRODUCT TYPES
    • TABLE 35: INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY FUNCTION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 34: INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT
  • FUNCTION, 2018 (%)
    • TABLE 36: U.S. INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY FUNCTION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 35: U.S. INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • TABLE 37: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL PRODUCT MARKET FOR RESEARCH BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 36: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL RESEARCH MARKET SHARES BY CELL TYPE, 2018 (%)
    • TABLE 38: INDUCED PLURIPOTENT STEM CELL RESEARCH MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 37: INDUCED PLURIPOTENT STEM CELL RESEARCH MARKET SHARES BY REGION, 2018 (%)
  • MAJOR PLAYERS
    • MAJOR COMMERCIAL ENTITIES
    • MAJOR NON-COMMERCIAL ORGANIZATIONS
      • Top Institutions Performing Induced Pluripotent Stem Cell Research
      • Induced Pluripotent Stem Cell Core Facilities
        • TABLE 39: MAJOR UNIVERSITY AND INSTITUTE INDUCED PLURIPOTENT STEM CELL CORE FACILITIES BY LOCATION
  • MARKET SHARES AND PROJECTIONS

CHAPTER 7 - DRUG DISCOVERY AND DEVELOPMENT MARKET

  • PRODUCT TYPES
  • MAJOR PLAYERS
  • MARKET SHARES AND PROJECTIONS
    • TABLE 40: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL PRODUCTS FOR DRUG DEVELOPMENT AND TOXICITY TESTING MARKET BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 38: INDUCED PLURIPOTENT STEM CELL-DRUG DEVELOPMENT AND TOXICITY TESTING MARKET SHARES BY CELL TYPE, 2018 (%)
    • TABLE 41: INDUCED PLURIPOTENT STEM CELL DRUG DEVELOPMENT AND TOXICITY TESTING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 39: INDUCED PLURIPOTENT STEM CELL DRUG DEVELOPMENT AND TOXICITY TESTING MARKET SHARES BY REGION, 2018 (%)

CHAPTER 8 - INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICE MARKET

  • INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICE TYPES
  • MAJOR PLAYERS
    • TABLE 42: MAJOR COMPANIES PROVIDING INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICES, 2013
  • MARKET SHARES AND PROJECTIONS
    • TABLE 43: INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICE MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 40: INDUCED PLURIPOTENT STEM CELL SERVICE MARKET SHARES BY REGION, 2018 (%)

CHAPTER 9 - INDUCED PLURIPOTENT STEM CELL CLINICAL APPLICATION MARKET

  • PRODUCT TYPES
  • REGULATIONS
  • MARKET PROJECTION
    • TABLE 44: INDUCED PLURIPOTENT STEM CELL PRODUCTS FOR REGENERATIVE MEDICINE MARKET BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 41: INDUCED PLURIPOTENT STEM CELL-DERIVED REGENERATIVE MEDICINE MARKET SHARES BY CELL TYPE, 2018 (%)
    • TABLE 45: INDUCED PLURIPOTENT STEM CELL CLINICAL MARKETS (INCLUDING PATIENT-SPECIFIC INDUCED PLURIPOTENT STEM CELL BANKING) BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 42: INDUCED PLURIPOTENT STEM CELL CLINICAL MARKET SHARES BY REGION, 2018 (%)

CHAPTER 10 - RESEARCH MARKET TREND ANALYSIS

  • GRANT ANALYSIS
    • TABLE 46: MAJOR GOVERNMENTAL INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING BY REGION, 2007-2013 ($ MILLIONS/%)
    • FIGURE 43: GOVERNMENTAL INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING BY REGION, 2007-2013 (%)
    • TABLE 47: NATIONAL INSTITUTES OF HEALTH INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING, 2007-2013 (NUMBER OF GRANTS/$ MILLIONS)
    • FIGURE 44: NATIONAL INSTITUTES OF HEALTH INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING, 2007-2013 ($ MILLIONS)
    • TABLE 48: CALIFORNIA INSTITUTE OF REGENERATIVE MEDICINE INDUCED PLURIPOTENT STEM CELL FUNDING, INCLUDING DIRECTLY REPROGRAMMED CELLS, THROUGH DECEMBER 24, 2013 (NUMBER/$ MILLIONS)
  • PATENT ANALYSIS
    • TABLE 49: INDUCED PLURIPOTENT STEM CELL PATENTS ISSUED BY THE U.S. PATENT AND TRADEMARK OFFICE, TO DECEMBER 2013
    • TABLE 50 U.S. PATENT AND TRADEMARK OFFICE-ISSUED PATENTS BY REGION, TO DECEMBER 2013 (NUMBER/%)
    • TABLE 51: INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION BY FILING OFFICE OR COUNTRY (NUMBER/%)
    • FIGURE 45: INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION BY FILING OFFICE OR COUNTRY (NUMBER)
    • TABLE 52: GLOBAL INDUCED PLURIPOTENT STEM CELL PATENTS OR PATENT APPLICATIONS (NUMBER/%)
    • TABLE 53 GLOBAL INDUCED PLURIPOTENT STEM CELL PATENT APPLICATIONS, DECEMBER 31, 2014 (NUMBER/%)
    • TABLE 54: WORLD INTELLECTUAL PROPERTY OFFICE INDUCED PLURIPOTENT STEM CELL PATENT PUBLICATIONS BY YEAR, 2007-2013 (NUMBER)
    • FIGURE 46: WORLD INTELLECTUAL PROPERTY OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATIONS, 2007-2013 (NUMBER)
    • TABLE 55: U.S. PATENT AND TRADEMARK OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATION TRENDS, 2009-2013 (NUMBER)
    • FIGURE 47: U.S. PATENT AND TRADEMARK OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATION TRENDS, 2009-2013 (NUMBER)
    • TABLE 56: GLOBAL INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION, THROUGH 2013 (NUMBER OF PATENTS/%)
    • TABLE 57: U.S. INDUCED PLURIPOTENT STEM CELL PATENTS AND PATENT APPLICATIONS BY STATE, THROUGH 2013 (NUMBER/%)
    • TABLE 58 WORLD INTELLECTUAL PROPERTY ORGANIZATION INDUCED PLURIPOTENT STEM CELL PATENT PUBLICATIONS BY CATEGORY, THROUGH 2013 (NUMBER/%)
  • SCIENTIFIC PUBLICATION ANALYSIS
    • TABLE 59: INDUCED PLURIPOTENT STEM CELL PUBLICATIONS, 2006-2013 (NUMBER)
    • FIGURE 48: INDUCED PLURIPOTENT STEM CELL PUBLICATIONS, 2006-2013 (NUMBER)
  • DRIVING FORCES

CHAPTER 11 - CLINICAL MARKET TREND ANALYSIS

  • CLINICAL TRIALS
  • DRIVING FORCES
  • LIMITING FACTORS
    • TECHNOLOGIES
    • REGULATIONS
    • MARKET ACCEPTANCE
    • CLINICAL EFFICIENCY

CHAPTER 12 - COMPANY PROFILES

  • AXIOGENESIS AG
  • CELLECTICS
  • CELLULAR DYNAMICS INC.
  • FATE THERAPEUTICS
  • IPERIAN
  • LONZA
  • REPROCELL INC.
  • STEMGENT INC.
  • SYSTEM BIOSCIENCES INC.
  • VIACYTE
  • WAISMAN BIOMANUFACTURING

CHAPTER 13 - CONCLUSIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 1: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY STATE, THROUGH 2018 ($ MILLIONS)
    • TABLE 2: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, THROUGH 2018 ($ MILLIONS)
    • TABLE 3: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, THROUGH 2018 ($ MILLIONS)
    • TABLE 4: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 5: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 6: INDUCED PLURIPOTENT STEM CELL-DERIVED TISSUE CELL MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 7: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • TABLE 8: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT SUPPLIERS, DECEMBER 31, 2013
    • TABLE 9: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL CELLULAR PRODUCT MANUFACTURERS, DECEMBER 31, 2013
    • TABLE 10: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 11: INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY PRODUCT FUNCTION, THROUGH 2018 ($ MILLIONS)
    • TABLE 12: U.S. INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKETS BY PRODUCT FUNCTION, THROUGH 2018 ($ MILLIONS)
    • TABLE 13: INDUCED PLURIPOTENT STEM CELL MARKETS, THROUGH 2018 ($ MILLIONS)
    • TABLE 14: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 15: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 16: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 17: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 18: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 19: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 20: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 21: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 22: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 23: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 24: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 25: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 26: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 27: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 28: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 29: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 30: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • TABLE 31: U.S. INDUCED PLURIPOTENT STEM CELLS AND DERIVATIVE CELLS MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • TABLE 32: EUROPEAN INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • TABLE 33: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELLS AND DERIVATIVE CELLS MARKET BY SPECIES, THROUGH 2018 ($ MILLIONS)
    • TABLE 34: CELL CULTURE PRODUCTS FOR INDUCED PLURIPOTENT STEM CELLS AND DERIVED CELLS MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 35: INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY FUNCTION, THROUGH 2018 ($ MILLIONS)
    • TABLE 36: U.S. INDUCED PLURIPOTENT STEM CELL-RELATED PRODUCT MARKET BY FUNCTION, THROUGH 2018 ($ MILLIONS)
    • TABLE 37: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL PRODUCT MARKET FOR RESEARCH BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 38: INDUCED PLURIPOTENT STEM CELL RESEARCH MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 39: MAJOR UNIVERSITY AND INSTITUTE INDUCED PLURIPOTENT STEM CELL CORE FACILITIES BY LOCATION
    • TABLE 40: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL PRODUCTS FOR DRUG DEVELOPMENT AND TOXICITY TESTING MARKET BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 41: INDUCED PLURIPOTENT STEM CELL DRUG DEVELOPMENT AND TOXICITY TESTING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 42: MAJOR COMPANIES PROVIDING INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICES, 2013
    • TABLE 43: INDUCED PLURIPOTENT STEM CELL CONTRACT SERVICE MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 44: INDUCED PLURIPOTENT STEM CELL PRODUCTS FOR REGENERATIVE MEDICINE MARKET BY CELL TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 45: INDUCED PLURIPOTENT STEM CELL CLINICAL MARKETS (INCLUDING PATIENT-SPECIFIC INDUCED PLURIPOTENT STEM CELL BANKING) BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 46: MAJOR GOVERNMENTAL INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING BY REGION, 2007-2013 ($ MILLIONS/%)
    • TABLE 47: NATIONAL INSTITUTES OF HEALTH INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING, 2007-2013 (NUMBER OF GRANTS/$ MILLIONS)
    • TABLE 48: CALIFORNIA INSTITUTE OF REGENERATIVE MEDICINE INDUCED PLURIPOTENT STEM CELL FUNDING, INCLUDING DIRECTLY REPROGRAMMED CELLS, THROUGH DECEMBER 24, 2013 (NUMBER/$ MILLIONS)
    • TABLE 49: INDUCED PLURIPOTENT STEM CELL PATENTS ISSUED BY THE U.S. PATENT AND TRADEMARK OFFICE, TO DECEMBER 2013
    • TABLE 50: U.S. PATENT AND TRADEMARK OFFICE-ISSUED PATENTS BY REGION, TO DECEMBER 2013 (NUMBER/%)
    • TABLE 51: INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION BY FILING OFFICE OR COUNTRY (NUMBER/%)
    • TABLE 52: GLOBAL INDUCED PLURIPOTENT STEM CELL PATENTS OR PATENT APPLICATIONS (NUMBER/%)
    • TABLE 53: GLOBAL INDUCED PLURIPOTENT STEM CELL PATENT APPLICATIONS, DECEMBER 31, 2014 (NUMBER/%)
    • TABLE 54: WORLD INTELLECTUAL PROPERTY OFFICE INDUCED PLURIPOTENT STEM CELL PATENT PUBLICATIONS BY YEAR, 2007-2013 (NUMBER)
    • TABLE 55: U.S. PATENT AND TRADEMARK OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATION TRENDS, 2009-2013 (NUMBER)
    • TABLE 56: GLOBAL INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION, THROUGH 2013 (NUMBER OF PATENTS/%)
    • TABLE 57: U.S. INDUCED PLURIPOTENT STEM CELL PATENTS AND PATENT APPLICATIONS BY STATE, THROUGH 2013 (NUMBER/%)
    • TABLE 58: WORLD INTELLECTUAL PROPERTY ORGANIZATION INDUCED PLURIPOTENT STEM CELL PATENT PUBLICATIONS BY CATEGORY, THROUGH 2013 (NUMBER/%)
    • TABLE 59: INDUCED PLURIPOTENT STEM CELL PUBLICATIONS, 2006-2013 (NUMBER)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, 2012-2018 ($ MILLIONS)
    • FIGURE 1: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 2: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY STATE, 2018 (%)
    • FIGURE 3: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS, MARKET SHARES, 2018 (%)
    • FIGURE 4: METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELL, MARKET SHARES, 2018 (%)
    • FIGURE 5: GLOBAL INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 6: U.S. INDUCED PLURIPOTENT STEM CELL PRODUCT MARKET BY APPLICATION, MARKET SHARES, 2018 (%)
    • FIGURE 7: INDUCED PLURIPOTENT STEM CELL-DERIVED TISSUE CELL MARKET SHARES BY TYPE, 2018 (%)
    • FIGURE 8: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL SUPPLIERS BY COUNTRY, 2013
    • FIGURE 9: MAJOR U.S. COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT SUPPLIERS BY STATE, 2013
    • FIGURE 10: MAJOR COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT MANUFACTURERS BY COUNTRY, 2013
    • FIGURE 11: MAJOR U.S. COMMERCIAL INDUCED PLURIPOTENT STEM CELL PRODUCT MANUFACTURERS BY STATE, 2013
    • FIGURE 12: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 13: INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • FIGURE 14: U.S. INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • FIGURE 15: INDUCED PLURIPOTENT STEM CELL MARKET SHARES, 2018 (%)
    • FIGURE 16: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 17: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 18: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 19: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN CARDIOMYOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 20: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 21: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 22: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 23: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN HEPATOCYTE MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 24: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 25: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 26: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 27: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN ENDOTHELIA CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 28: INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 29: U.S. INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 30: EUROPEAN INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 31: ASIA-PACIFIC INDUCED PLURIPOTENT STEM CELL-DERIVED HUMAN NEURAL CELL MARKET SHARES BY APPLICATION, 2018 (%)
    • FIGURE 32: INDUCED PLURIPOTENT STEM CELL AND DERIVATIVE CELL MARKET SHARES BY SPECIES, 2018 (%)
    • FIGURE 33: INDUCED PLURIPOTENT STEM CELL CULTURE PRODUCT MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 34: INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • FIGURE 35: U.S. INDUCED PLURIPOTENT STEM CELL MARKET SHARES BY PRODUCT FUNCTION, 2018 (%)
    • FIGURE 36: INDUCED PLURIPOTENT STEM CELL-DERIVED CELL RESEARCH MARKET SHARES BY CELL TYPE, 2018 (%)
    • FIGURE 37: INDUCED PLURIPOTENT STEM CELL RESEARCH MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 38: INDUCED PLURIPOTENT STEM CELL-DRUG DEVELOPMENT AND TOXICITY TESTING MARKET SHARES BY CELL TYPE, 2018 (%)
    • FIGURE 39: INDUCED PLURIPOTENT STEM CELL DRUG DEVELOPMENT AND TOXICITY TESTING MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 40: INDUCED PLURIPOTENT STEM CELL SERVICE MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 41: INDUCED PLURIPOTENT STEM CELL-DERIVED REGENERATIVE MEDICINE MARKET SHARES BY CELL TYPE, 2018 (%)
    • FIGURE 42: INDUCED PLURIPOTENT STEM CELL CLINICAL MARKET SHARES BY REGION, 2018 (%)
    • FIGURE 43: GOVERNMENTAL INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING BY REGION, 2007-2013 (%)
    • FIGURE 44: NATIONAL INSTITUTES OF HEALTH INDUCED PLURIPOTENT STEM CELL RESEARCH FUNDING, 2007-2013 ($ MILLIONS)
    • FIGURE 45: INDUCED PLURIPOTENT STEM CELL PATENT AND PATENT APPLICATION DISTRIBUTION BY FILING OFFICE OR COUNTRY (NUMBER)
    • FIGURE 46: WORLD INTELLECTUAL PROPERTY OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATIONS, 2007-2013 (NUMBER)
    • FIGURE 47: U.S. PATENT AND TRADEMARK OFFICE INDUCED PLURIPOTENT STEM CELL PATENT APPLICATION TRENDS, 2009-2013 (NUMBER)
    • FIGURE 48: INDUCED PLURIPOTENT STEM CELL PUBLICATIONS, 2006-2013 (NUMBER)
Back to Top